Neuro-Oncology Reviews
Volume
27 Number 35
20 December 2025
Home > Publications > Neuro-Oncology Reviews > Volume 27, Year 2025 > Number 35, 20 December
Drappatz J, Mantica M.
Treatment
strategies and innovation for recurrent high-grade glioma.
J
Neurooncol. 2025 Dec 11;176(1):118. doi:
10.1007/s11060-025-05323-3. PMID:
41381983. Review˰
ˍ
Drapkin AJ.
On the question of
prognosis in cystic gliomas.
World
Neurosurg. 2025 Dec 11:124714. doi:
10.1016/j.wneu.2025.124714. PMID:
41390081. Perspective. ˍ
McKerill E, Tan JK, Rao CK, Linares CA, Banerjee S, Rabbani RD,
Adeleke S, Ghose A, Boussios S.
Efficacy
of ketogenic metabolic therapy as an adjuvant to the current
standard of care in the treatment of glioblastoma: A systematic
review of clinical trials.
Med
Oncol. 2025 Dec 11;43(1):49. doi:
10.1007/s12032-025-03165-7. PMID:
41379280. Review. ˍ
Pérez-Alfayate R, Paz-Cabezas M, Pérez-Segura P,
Sanchez Del Hoyo R, Cabezas-Camarero S.
Cerebrospinal
fluid ctDNA as a diagnostic and prognostic tool in gliomas: a
systematic review and meta-analysis.
Front
Oncol. 2025 Dec 11;15:1714287. doi:
10.3389/fonc.2025.1714287. PMID:
41458584. Review; Meta-analysis. ˍ
Ehret F, Rogers CL, Fontanesi J, Wilson GD, Chitti BS, Starner J,
Sidiqi B, Goenka A, Schulder M, Bruynzeel AME, Verhoeff JJC,
MacDonagh AC, Park HI, Shih HA, Kleinberg L.
Radiation
Therapy for Non-Malignant Central Nervous System Tumors,
Disorders, and Illnesses - Current Applications and Future
Directions.
Semin
Radiat Oncol. 2025 Dec 12;36:77-94. doi:
10.1016/j.semradonc.2025.08.005. PMID:
41391900. Review. ˍ
Scagliotti E, Capetti B, Conti L, Fiore G, Fanizzi C, Bertani G,
Pravettoni G, Locatelli M.
Effects of
proton therapy on cognition in adults with brain tumors: a
systematic review.
J
Neurooncol. 2025 Dec 12;176(1):121. doi:
10.1007/s11060-025-05371-9. PMID:
41385035. Review˰
ˍ
Jia L, Chen Y, Li H, Zhao K, Ge S, Wang C, Zhao J, Li F, Zhang L,
Yao A.
The glymphatic system in
neurodegenerative diseases and brain tumors: mechanistic insights,
biomarker advances, and therapeutic opportunities.
Acta
Neuropathol Commun. 2025 Dec 13. doi:
10.1186/s40478-025-02203-9. PMID:
41390476. Review. ˍ
Karsonovich T, Gasalberti DP, Rayi A.
Low-Grade
Gliomas.
StatPearls
Publishing, Treasure Island (FL), 2025 Dec 13. PMID:
32809503. Bookshelf
ID: NBK560668. Book. ˍ
Love CA, Figg JW, Engelbart M, West I, Flores C.
Radial
glial cells and glioblastoma: how developmental neurobiology can
inform our understanding of brain cancer initiation, treatment
resistance, and resilience.
Transl
Oncol. 2025 Dec 13;64:102645. doi:
10.1016/j.tranon.2025.102645. PMID:
41391380. Review. ˍ
Podder V, Sarfraz Z, Qidwai KA, Maharaj A, Ranjan T, Aulakh S,
Ahluwalia MS.
Gaps in Diagnosis,
Treatment, and Outcomes Among Patients with Brain Tumors in the
United States: A State-of-the-Art Review. Cancers
(Basel). 2025 Dec 13;17(24):3982. doi:
10.3390/cancers17243982. PMID:
41463231. Review. ˍ
Boffelli L, Fimiani C, Núñez NG, Kienzler JC.
Synergy of radiotherapy, focused
ultrasound, and immunotherapy in the treatment of brain
metastases.
J
Neurooncol. 2025 Dec 15;176(1):124. doi:
10.1007/s11060-025-05379-1. PMID:
41396538. Review. ˍ
Wong ET, Lok E.
Transnasal drug
delivery to the brain: circumventing barriers for brain tumor
patients.
Am
J Transl Res. 2025 Dec 15;17(12):9466-9477. doi:
10.62347/BERU9082. PMID:
41552350. Review. ˍ
Flores T, Delpierre E, Male G, Gourin C, Hantz S, Damour A, Ligat
G.
Targeting Human Cytomegalovirus as
a Novel Approach for Glioblastoma Treatment.
Pathogens.
2025 Dec 16;14(12):1291. doi:
10.3390/pathogens14121291. PMID:
41471245. Review. ˍ
Sadhasivam S, Velpula S, Prasanna L, Arora RK, Menon G, Nair SN.
Impact of awake mapping on extent of
resection and neurological outcomes of Low-grade gliomas: a
systematic review and Meta-analysis.
Neurosurg
Rev. 2025 Dec 16;49(1):74. doi:
10.1007/s10143-025-03998-w. PMID:
41398134. Review; Meta-analysis˰
ˍ
Wang B, Li C, Gu J, Wang X, Xun M, Jiang B, Yan J.
Targeting
glioma-associated microglia and macrophages: a new frontier in
glioblastoma immunotherapy.
Front
Immunol. 2025 Dec 17;16:1726440. doi:
10.3389/fimmu.2025.1726440. PMID:
41479886. Review. ˍ
Królikowska K, Błaszczak K, Ławicki S, Zajkowska
M, Gudowska-Sawczuk M.
Glioblastoma-A
Contemporary Overview of Epidemiology, Classification,
Pathogenesis, Diagnosis, and Treatment: A Review Article.
Int
J Mol Sci. 2025 Dec 18;26(24):12162. doi:
10.3390/ijms262412162. PMID:
41465586. Review. ˍ
Al Sharie S, Sawaftah K, Qasim H, Al-Hussaini M.
Methylation
profiling in neuropathological tumors diagnosis: a comprehensive
review.
Front
Oncol. 2025 Dec 19;15:1720458. doi:
10.3389/fonc.2025.1720458.
PMID:
41487568. Review. ˍ
Eibl RH, Schneemann M.
Circulating
Tumor Cells in Glioblastoma.
Cancers
(Basel). 2025 Dec 19;18(1):10. doi:
10.3390/cancers18010010. PMID:
41514523. Review. ˍ
Nakhaei A, Afshari S, Mohammadian M, Ahmadi SS, Mohatshami E,
Jalili-Nik M, Jalali M, Karav S, Afshari AR, Kesharwani P,
Sahebkar A.
Harnessing the role of
insulin-like growth factor in glioblastoma: a comprehensive
review.
Neuroscience.
2025 Dec 19;594:172-186. doi:
10.1016/j.neuroscience.2025.12.044. PMID:
41423020. Review˰ ˍ
Pang C, Wang Y.
The Immunosuppressive
Microenvironment of Glioblastoma: Mechanisms, Clinical Challenges
and Future Directions.
Immunology.
2025 Dec 19. doi:
10.1111/imm.70087. PMID:
41414954. Review. ˍ
Raja M, Quintero G, Lone YC, Trojan J.
Impact
of Nanotechnology on Glioblastoma Studies: From Brain Stem Cells
to Neoplastic Development and Cancer Gene Therapy.
Front
Biosci (Elite Ed). 2025 Dec 19;17(4):38600. doi:
10.31083/FBE38600. PMID:
41504090. Review. ˍ